- Home
- RVTY vs FMS Comparison
RVTY vs FMS Comparison
Compare RVTY & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVTY | FMS |
|---|---|---|
| Founded | 1937 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 13.9B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | RVTY | FMS |
|---|---|---|
| Price | $117.74 | $22.36 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 14 | 2 |
| Target Price | ★ $113.46 | $30.00 |
| AVG Volume (30 Days) | ★ 1.2M | 540.0K |
| Earning Date | 02-02-2026 | 02-24-2026 |
| Dividend Yield | 0.24% | ★ 2.63% |
| EPS Growth | N/A | ★ 8.62 |
| EPS | 1.99 | ★ 2.86 |
| Revenue | $2,813,367,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $5.30 | $2.13 |
| Revenue Next Year | $3.03 | $2.95 |
| P/E Ratio | $58.51 | ★ $14.21 |
| Revenue Growth | ★ 3.37 | 2.10 |
| 52 Week Low | $81.36 | $20.95 |
| 52 Week High | $128.29 | $30.46 |
Technical Indicators
Market Signals| Indicator | RVTY | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 72.70 | 45.45 |
| Support Level | $110.17 | $20.96 |
| Resistance Level | $115.78 | $22.10 |
| Average True Range (ATR) | 4.18 | 0.47 |
| MACD | 1.41 | -0.12 |
| Stochastic Oscillator | 96.73 | 48.07 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.